GaviLyte-H Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with GaviLyte-H
K
- Kadian (morphine)
- Kaletra (lopinavir / ritonavir)
- ketamine / midazolam / ondansetron
- Ketek (telithromycin)
- Ketek Pak (telithromycin)
- ketoconazole
- ketoprofen
- ketorolac
- Keveyis (dichlorphenamide)
- KG Hist DM (brompheniramine / dextromethorphan / phenylpropanolamine)
- KG-Dal HD (chlorpheniramine / hydrocodone / phenylephrine)
- KG-Dal HD Plus (chlorpheniramine / hydrocodone / phenylephrine)
- KG-Fed (codeine / pseudoephedrine)
- KG-Fed Expectorant (codeine / guaifenesin / pseudoephedrine)
- KG-Fed Pediatric Expectorant (codeine / guaifenesin / pseudoephedrine)
- KG-Hist D (pheniramine / phenylpropanolamine / phenyltoloxamine / pyrilamine)
- KG-Tuss HD (guaifenesin / hydrocodone / pseudoephedrine)
- KG-Tussin (chlorpheniramine / hydrocodone / pseudoephedrine)
- KGS-HC (hydrocodone / potassium guaiacolsulfonate)
- Khedezla (desvenlafaxine)
- KIE (ephedrine / potassium iodide)
- Kimmtrak (tebentafusp)
- Kiprofen (ketoprofen)
- Kisqali (ribociclib)
- Kisqali Femara Co-Pack (letrozole / ribociclib)
- KneeRelief (acetaminophen / caffeine / magnesium salicylate)
- Kondremul with Phenolphtalein (mineral oil / phenolphthalein)
- Kophane (chlorpheniramine / dextromethorphan / phenylpropanolamine)
- Korlym (mifepristone)
- Krazati (adagrasib)
- Kristalose (lactulose)
- Kwelcof (guaifenesin / hydrocodone)
- Kynmobi (apomorphine)
- Kytril (granisetron)
More about GaviLyte-H (polyethylene glycol 3350 with electrolytes)
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: laxatives
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.